Evidence map›Paper›PMID 36361647›Full record

ReviewInternational journal of molecular sciences2022

Development and Applications of CRISPR/Cas9-Based Genome Editing in

Yulin Mu, Chengxiao Zhang, Taihua Li, Feng-Jie Jin, Yun-Ju Sung, Hee-Mock Oh, Hyung-Gwan Lee, Long Jin

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. The Role of the Gut Microbiome in Type 2 Diabetes Mellitus.International journal of molecular sciences · 2025
    Review
  7. Review
  8. Review
  9. Review
  10. Foods (Basel, Switzerland) · 2025
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. HarnessingCurrent research in microbial sciences · 2025
    Review
  16. Review
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yulin MuCollege of Biology and the Environment, Nanjing Forestry University, Nanjing 210037, China.ORCID 0000-0002-2277-5443
Chengxiao ZhangCollege of Biology and the Environment, Nanjing Forestry University, Nanjing 210037, China.ORCID 0000-0003-3222-8555
Taihua LiCollege of Biology and the Environment, Nanjing Forestry University, Nanjing 210037, China.
Feng-Jie JinCollege of Biology and the Environment, Nanjing Forestry University, Nanjing 210037, China.ORCID 0000-0003-0376-0964
Yun-Ju SungBioNanotechnology Research Centre, Korea Research Institute of Bioscience & Biotechnology (KRIBB), Daejeon 34141, Korea.
Hee-Mock OhCell Factory Research Centre, Korea Research Institute of Bioscience & Biotechnology (KRIBB), Daejeon 34141, Korea.
Hyung-Gwan LeeCell Factory Research Centre, Korea Research Institute of Bioscience & Biotechnology (KRIBB), Daejeon 34141, Korea.
Long JinCollege of Biology and the Environment, Nanjing Forestry University, Nanjing 210037, China.ORCID 0000-0003-3808-5217

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CRISPR-Cas SystemsGene EditingAnimalsLactobacillusMammalsCas9 proteinCRISPR/Cas9genome editingLactobacillus

Identifiers

PMID36361647
PMCPMC9656040

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.